Yonghui Su

868 total citations
17 papers, 655 citations indexed

About

Yonghui Su is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Yonghui Su has authored 17 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 9 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Yonghui Su's work include Breast Cancer Treatment Studies (6 papers), Circular RNAs in diseases (4 papers) and Cancer-related molecular mechanisms research (3 papers). Yonghui Su is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Circular RNAs in diseases (4 papers) and Cancer-related molecular mechanisms research (3 papers). Yonghui Su collaborates with scholars based in China, Switzerland and United States. Yonghui Su's co-authors include Jiong Wu, Weiru Chi, Jingyu Wang, Xiao Wang, Lan Yao, Rong Guo, Bingqiu Xiu, Yuchen Li, Jingjing Zhao and Zhen Wang and has published in prestigious journals such as Cancer, Clinical Chemistry and Theranostics.

In The Last Decade

Yonghui Su

17 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yonghui Su China 11 433 432 127 85 63 17 655
Dineika Chandrananda United Kingdom 11 324 0.7× 525 1.2× 88 0.7× 197 2.3× 201 3.2× 16 653
Sabine Weickmann Germany 13 568 1.3× 460 1.1× 36 0.3× 129 1.5× 205 3.3× 17 749
Ehab Husain United Kingdom 11 118 0.3× 129 0.3× 67 0.5× 135 1.6× 57 0.9× 25 398
Evan Gomes-Giacoia United States 8 190 0.4× 138 0.3× 135 1.1× 128 1.5× 53 0.8× 9 424
Laure Sorber Belgium 10 291 0.7× 420 1.0× 32 0.3× 172 2.0× 211 3.3× 15 543
Anna Antenucci Italy 11 226 0.5× 222 0.5× 22 0.2× 35 0.4× 79 1.3× 18 446
Marija Debeljak United States 10 152 0.4× 185 0.4× 166 1.3× 266 3.1× 124 2.0× 16 479
Michela Tebaldi Italy 11 184 0.4× 109 0.3× 60 0.5× 152 1.8× 138 2.2× 23 442
Tianzhu Lu China 15 195 0.5× 142 0.3× 192 1.5× 213 2.5× 156 2.5× 59 614
Feng Lou China 10 161 0.4× 334 0.8× 68 0.5× 186 2.2× 324 5.1× 40 529

Countries citing papers authored by Yonghui Su

Since Specialization
Citations

This map shows the geographic impact of Yonghui Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonghui Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonghui Su more than expected).

Fields of papers citing papers by Yonghui Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonghui Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonghui Su. The network helps show where Yonghui Su may publish in the future.

Co-authorship network of co-authors of Yonghui Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yonghui Su. A scholar is included among the top collaborators of Yonghui Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonghui Su. Yonghui Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Su, Yonghui, et al.. (2025). Highly efficient NIR-II photothermal therapy amplified ROS oxide breast tumor therapy by mesoporous gallium-enriched platinum nanomedicine. Materials Today Bio. 32. 101869–101869. 2 indexed citations
2.
Guo, Rong, Yonghui Su, Qi Zhang, et al.. (2023). LINC00478-derived novel cytoplasmic lncRNA LacRNA stabilizes PHB2 and suppresses breast cancer metastasis via repressing MYC targets. Journal of Translational Medicine. 21(1). 120–120. 12 indexed citations
3.
Si, Jing, Rong Guo, Bingqiu Xiu, et al.. (2022). Stabilization of CCDC102B by Loss of RACK1 Through the CMA Pathway Promotes Breast Cancer Metastasis via Activation of the NF-κB Pathway. Frontiers in Oncology. 12. 927358–927358. 8 indexed citations
4.
Su, Yonghui, Yuchen Li, Rong Guo, et al.. (2021). Plasma extracellular vesicle long RNA profiles in the diagnosis and prediction of treatment response for breast cancer. npj Breast Cancer. 7(1). 154–154. 31 indexed citations
6.
Wang, Jia, Bingqiu Xiu, Rong Guo, et al.. (2020). Autologous tissue reconstruction after mastectomy–A cross-sectional survey of 110 hospitals in China. European Journal of Surgical Oncology. 46(12). 2202–2207. 5 indexed citations
7.
Xiu, Bingqiu, Rong Guo, Qin Zhang, et al.. (2020). [Current trend of breast cancer neoadjuvant treatment in China: a cross-sectional study].. PubMed. 42(11). 931–936. 2 indexed citations
8.
Li, Lun, Yonghui Su, Bingqiu Xiu, et al.. (2019). Comparison of prepectoral and subpectoral breast reconstruction after mastectomies: A systematic review and meta analysis. European Journal of Surgical Oncology. 45(9). 1542–1550. 76 indexed citations
9.
Wang, Jingyu, et al.. (2019). <p>Exosome-Mediated Transfer of lncRNA HOTTIP Promotes Cisplatin Resistance in Gastric Cancer Cells by Regulating HMGA1/miR-218 Axis</p>. OncoTargets and Therapy. Volume 12. 11325–11338. 88 indexed citations
10.
Huang, Sheng, Yayun Chi, Weiru Chi, et al.. (2019). LINC00309 is associated with short disease-free survival in breast cancer. Cancer Cell International. 19(1). 210–210. 3 indexed citations
11.
Guo, Rong, Jing Si, Yonghui Su, et al.. (2019). Changing patterns and survival improvements of young breast cancer in China and SEER database, 1999−2017. Chinese Journal of Cancer Research. 31(4). 653–662. 27 indexed citations
12.
Guo, Rong, Lun Li, Yonghui Su, et al.. (2019). Current practice and barriers of mesh-assisted implant-based breast reconstruction in China: A nationwide cross-sectional survey of 110 hospitals. European Journal of Surgical Oncology. 46(1). 65–70. 8 indexed citations
13.
Li, Yuchen, Jingjing Zhao, Shulin Yu, et al.. (2019). Extracellular Vesicles Long RNA Sequencing Reveals Abundant mRNA, circRNA, and lncRNA in Human Blood as Potential Biomarkers for Cancer Diagnosis. Clinical Chemistry. 65(6). 798–808. 214 indexed citations
14.
Su, Yonghui, Rong Guo, Jingyan Xue, et al.. (2019). Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence. The Oncologist. 24(9). e818–e827. 25 indexed citations
15.
Huang, Sheng, Yayun Chi, Yi Qin, et al.. (2018). CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription. Theranostics. 8(9). 2549–2564. 42 indexed citations
16.
Shan, Ming, et al.. (2016). Aberrant expression and functions of protocadherins in human malignant tumors. Tumor Biology. 37(10). 12969–12981. 20 indexed citations
17.
Shan, Ming, Junnan Li, Xiaobo Li, et al.. (2016). Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer. Oncotarget. 7(14). 18485–18494. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026